KYAD13-2019-112P3

N/A

Report date: 2025/10/28 16:42:44

Base Information

Drug NameKYAD13-2019-112P3
Drug Alias NameKYAD13-2019-112P3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDelirium
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina Resources Sanjiu Medical & Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDelirium
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A